Clinical implications of girdin protein expression in glioma

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Zhao, Liwei ^a   Ma, Shuyin ^a   Liu, Qing ^a   Liang, Peng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GIRDIN; KI 67 ANTIGEN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CCDC88A PROTEIN, HUMAN; TUMOR MARKER; VESICULAR TRANSPORT PROTEIN;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CYTOPLASM; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; WESTERN BLOTTING; WORLD HEALTH ORGANIZATION; ADULT; AGED; BRAIN TUMOR; GENETICS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; GLIOMA; HUMANS; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

EID: 84888878007     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/986073     Document Type: Article

References (17)

1. Toda M., Glioma stem cells and immunotherapy for the treatment of malignant gliomas. ISRN Oncology 2013 2013 13 10.1155/2013/673793 673793
2. De Bonis P., Lofrese G., Anile C., Pompucci A., Vigo V., Mangiola A., Radioimmunotherapy for high-grade glioma. Immunotherapy 2013 5 6 647 659
3. Vlachostergios P. J., Voutsadakis I. A., Papandreou C. N., The role of ubiquitin-proteasome system in glioma survival and growth. Growth Factors 2013 31 3 106 113
4. Hart M. G., Grant R., Garside R., Rogers G., Somerville M., Stein K., Temozolomide for high grade glioma. Cochrane Database of Systematic Reviews 2008 4 CD007415 2-s2.0-58249093743
5. Nadaj-Pakleza A. A., Dorobek M., Nestorowicz K., Ryniewicz B., Szmidt-Sałkowska E., Kamińska A. M., Reoperations of patients with low-grade gliomas in eloquent or near eloquent brain areas. Neurologia i Neurochirurgia Polska 2013 47 3 214 222
6. Kim H., Choi S. H., Kim J. H., Gliomas:application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading. PLoS ONE 2013 8 5 e63462
7. Xu H. W., Huang Y. J., Xie Z. Y., The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients. BMC Cancer 2013 13, article 247
8. Wu W., Tian Y., Wan H., Song Y., Li J., Zhang L., The expressions of Wnt/ β -catenin pathway-related components in brainstem gliomas. Canadian Journal of Neurological Sciences 2013 40 3 355 360
9. Ghosh P., Beas A. O., Bornheimer S. J., Garcia-Marcos M., Forry E. P., Johannson C., Ear J., Jung B. H., Cabrera B., Carethers J. M., Farquhar M. G., A G α i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Molecular Biology of the Cell 2010 21 13 2338 2354 2-s2.0-77954208220 10.1091/mbc.E10-01-0028
10. Enomoto A., Ping J., Takahashi M., Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways. Annals of the New York Academy of Sciences 2006 1086 169 184 2-s2.0-34447544399 10.1196/annals.1377.016 (Pubitemid 47084384)
11. Jin F., Liu C., Guo Y., Chen H., Wu Y., Clinical implications of Girdin and PI3K protein expression in breast cancer. Oncology Letters 2013 5 5 1549 1553
12. López-Sánchez I., Garcia-Marcos M., Mittal Y., Aznar N., Farquhar M. G., Ghosh P., Protein kinase C-theta (PKC θ) phosphorylates and inhibits the guanine exchange factor, GIV/Girdin. Proceedings of the National Academy of Sciences of the United States of America 2013 110 14 5510 5515
13. Millet P., Granotier C., Etienne O., Boussin F. D., Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines. International Journal of Oncology 2013 43 2 375 382
14. Natsume A., Kinjo S., Yuki K., Kato T., Ohno M., Motomura K., Iwami K., Wakabayashi T., Glioma-initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathology 2011 28 1 1 12 2-s2.0-78951487499 10.1007/s10014-010-0011-3
15. Natsume A., Kato T., Kinjo S., Enomoto A., Toda H., Shimato S., Ohka F., Motomura K., Kondo Y., Miyata T., Takahashi M., Wakabayashi T., Girdin maintains the stemness of glioblastoma stem cells. Oncogene 2012 31 22 2715 2724 2-s2.0-80054731427 10.1038/onc.2011.466
16. Hernández-Pedro N. Y., Rangel-López E., Magaña-Maldonado R., de la Cruz V. P., del Angel A. S., Pineda B., Sotelo J., Application of nanoparticles on diagnosis and therapy in gliomas. BioMed Research International 2013 2013 20 10.1155/2013/351031 351031
17. Natsume A., Kato T., Kinjo S., Enomoto A., Toda H., Shimato S., Ohka F., Motomura K., Kondo Y., Miyata T., Takahashi M., Wakabayashi T., Girdin maintains the stemness of glioblastoma stem cells. Oncogene 2012 31 22 2715 24 2-s2.0-80054731427 10.1038/onc.2011.466